Mandate

Vinge is advising Vimian Group AB (publ) (“Vimian”) and the principal shareholder Fidelio Capital AB (“Fidelio”) in connection with a private placement and subsequent listing on Nasdaq First North Growth Market with first day of trading on 18 June 2021

June 18, 2021 Banking and Finance M&A

Vinge is advising Vimian and the principal shareholder Fidelio in connection with a private placement and subsequent listing on Nasdaq First North Growth Market with first day of trading on 18 June 2021, and also with the reorganization preceding the listing. The price in the private placement values Vimian to c. SEK 29.6 billion.

Related

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of their production facility in Uppsala to Ofichem. The Uppsala site specializes in small-scale, early-phase development work.
August 13, 2025

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025